NCT01472640View on ClinicalTrials.gov

The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
HyperglycemiaChronic Heart Failure
Interventions
DRUG

liraglutide

1.8 mg sc QOD

DRUG

placebo

1 U sc QOD

Trial Locations (4)

2730

Herlev University Hospital, Herlev

2820

Steno Diabetes Center, Gentofte Municipality

5000

Odense University Hospital, Odense

8200

Skejby University Hospital, Aarhus

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Flyvbjerg, Allan, DMSc

INDIV